Simply Wall St.
This Talphera Insider Increased Their Holding By 138% Last Year
📊
AI Sentiment
Positive
6/10
- Home
- TLPH
TLPH
Talphera Inc.
as of 12-10-2025 3:45pm EST
$1.27
+$0.04
+3.25%
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Chart Type:
Time Range:
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | SAN MATEO |
| Market Cap: | 64.7M | IPO Year: | 2011 |
| Target Price: | $6.00 | AVG Volume (30 days): | 366.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.39 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.38 - $1.57 | Next Earning Date: | 11-12-2025 |
| Revenue: | $28,000 | Revenue Growth: | -90.04% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 14267.20% |
AI-Powered TLPH Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 65.28%
65.28%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Talphera Inc. News
TLPH Breaking Stock News: Dive into TLPH Ticker-Specific Updates for Smart Investing
Compare TLPH vs Leading Stocks
See how TLPH stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "TLPH Talphera Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.